Exemestane
Product Images NDC 50090-5193

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 50090-5193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

The text provides a figure that shows the disease-free survival of postmenopausal women with early breast cancer. The graph shows the proportion of patients surviving the disease over time (in months) and compares the treatment of exemestane to tamoxifen. The HR (Hazard Ratio) and P (p-value) are also indicated in the text, which are statistical measures of the effectiveness of the treatment showing that exemestane is more effective than tamoxifen.*

FDA Label Image

Figure-2 (Figure 2)

The text provides a figure titled "Time to Tumor Progression in the Comparative Study of Postmenopausal Women with Advanced Breast Cancer" and shows the number of PDs (progressive diseases) per number of patients for Exemestane and Megestrol Acetate. The figure is labeled with time in weeks on the x-axis and PDs/pts. on the y-axis. Therefore, it is related to the probability of tumor progression in postmenopausal women with advanced breast cancer after tamoxifen therapy.*

FDA Label Image

Label Image (Lbl500905193)

Product No. 9536-6 is a DenesTane s medication that comes in a case containing 2430 tablets. The recommended storage temperature for the medication is 77 degrees Fahrenheit.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.